FDA panel recommends new diet drug Qnexa Vivus Shares Surge After Panel Backs Diet Drug WeightLoss approval may pave way for another antiobesity advisors endorse weightloss OKs previously rejected pill shares soar after vote on obesity Use Caution Vivus' Victory 1st in 13 years gets initial OK Pill Wins Backing of Advisory Panel’s Support If the green light who would get U.S. advisers back experimental should be approved says

Qnexa approval may pave way for another obesity drug An FDA advisory committee's endorsement of the anti-obesity drug Qnexa Wednesday could re-energized the pharmaceutical industry after several years of disappointment in trying to develop anti-obesity drugs. The committee voted 20 to 2 to recommend approval of Qnexa, which is a combination of two existing drugs, the appetite suppressant phentermine and the anti-seizure medication topiramate. The ... Panel recommends FDA OK obesity drug Qnexa Experimental obesity drug Qnexa won the backing of U.S. health advisers, raising hopes for approval of the first prescription weight-loss pill in 13 years. FDA's Qnexa Nod Sparks Praise, Criticism The decision by a federal advisory panel on Wednesday to recommend Qnexa for approval by the U.S. Food and Drug Administration is drawing praise and criticism from obesity and diet experts, reflecting a still-hot debate on the need for additional tools to treat obesity. Vivus Doubles After Panel Backs Its Qnexa Weight-Loss Pill Vivus Inc. doubled in trading after the company's pill Qnexa won the backing of a regulatory panel, moving the drug a step closer to gaining U.S. approval as the first new obesity treatment in 13 years. FDA advisors endorse weight-loss drug Qnexa In a reversal, an FDA advisory committee backs the weight-loss drug Qnexa despite health risks after its maker, Vivus, promises strict oversight. A panel of medical experts voted overwhelmingly Wednesday to endorse the controversial weight-loss drug Qnexa, clearing the way for the Food and Drug Administration to approve a new prescription obesity medication for the first time since 1999. Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Panel Vivus Inc.'s weight-loss pill Qnexa won the backing of a U.S. advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years. The shares doubled in late trading. Diet drug Qnexa should be approved, panel says The diet drug Qnexa has cleared a major hurdle toward eventual Food and Drug Administration approval. An independent panel of medical experts who advise the agency voted Wednesday that Qnexa's significant weight-loss benefit outweighed its potential risks. Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Advisory Panel Vivus Inc. (VVUS) 's weight-loss pill Qnexa won the backing of a U.S. advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years. If Qnexa gets the green light, who would get the drug? An advisory committee's hearty 20-to-2 vote to recommend approval of the obesity drug Qnexa on Wednesday means it's highly likely the FDA will allow the medication to be marketed when the agency issues its final report later this year. If approved, Qnexa will be the first new prescription weight-loss medication in 13 years. Qnexa Diet Pill Gets Green Light, FDA Decision Expected in April Qnexa diet pills are likely to be the first anti-obesity drug to be approved by the FDA after a federal panel backed it by a vote of 20-2
Key Words: qnexa

References:
http://www.philly.com/r?19=961&43=165801&44=140090733&32=3796&7=195352&40=http%3A%2F%2Fwww.philly.com%2Fphilly%2Fbusiness%2F20120223_FDA_panel_recommends_new_diet_drug_Qnexa.html
http://online.wsj.com/article/SB10001424052970203960804577241220152561402.html?mod=rss_whats_news_us
http://online.wsj.com/article/SB10001424052970203960804577239642544675320.html?mod=rss_whats_news_us
http://ChicagoTribune.feedsportal.com/c/34253/f/622900/s/1ce320a1/l/0L0Schicagotribune0N0Chealth0Cla0Eheb0Eqnexa0Eobesity0Edrugs0E20A120A2230H0A0H19420A350Bstory0Dtrack0Frss/story01.htm
http://feeds.latimes.com/~r/latimes/news/science/~3/E8KkIvdBTOs/la-he-qnexa-fda-20120223,0,7015694.story
http://feeds.reuters.com/~r/reuters/topNews/~3/fCzaxVtzUkU/us-fda-obesity-vivus-idUSTRE81L2AS20120223
http://ChicagoTribune.feedsportal.com/c/34253/f/622900/s/1cdbd44a/l/0L0Schicagotribune0N0Chealth0Cla0Eheb0Eqnexa0Efda0E20A120A2220H0A0H73133580Bstory0Dtrack0Frss/story01.htm
http://pixelhat.net/